To cite this paper use one of the standards below:
A novel series of nitrogen-containing heterocycles combining tetrahydroquinoline (THQ) and triazole scaffolds was successfully designed, synthesized and characterized as potential inhibitors of enzymes related to Alzheimer's disease (acetylcholinesterase/butyrylcholinesterase). The synthetic protocol involved a ZnCl2-catalyzed Povarov reaction for the THQ scaffold, followed by amine propargylation and copper-catalyzed azide-alkyne cycloaddition for the final structure. Given the multifactorial nature of the disease, the compounds were evaluated as cholinesterase inhibitors using Ellman’s Method and as antioxidants (DPPH/ABTS assay). Preliminary screening revealed a remarkable selective antioxidant capacity against ABTS radicals (EC50<10μg/mL), while five of the compounds exhibited a promising dual anticholinesterase profile, highlighting T4 (IC50 AChE=3.77± 0.31 μM, BChE=18.38 ± 0.45 μM) and T13 (IC50 AChE=4.85 ± 0.30 μM, BChE=14.82 ± 0.88 μM).These results were complemented by molecular docking studies to elucidate the binding modes within the enzymatic active sites, concluding that the THQ-Triazole framework represents a promising structure for anti-Alzheimer multitarget drug discovery.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper